| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |